| Identification | Back Directory | [Name]
N-(3-(2-(2-(3-Aminopropoxy)ethoxy)ethoxy)propyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide Trifluoroacetate | [CAS]
1799711-29-7 | [Synonyms]
Thalidomide-O-amido-C3-PEG3-C1-NH2
N-(3-(2-(2-(3-Aminopropoxy)ethoxy)ethoxy)propyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide Trifluoroacetate
N-(3-(2-(2-(3-Aminopropoxy)ethoxy)ethoxy)propyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide 2,2,2-trifluoroacetate | [Molecular Formula]
C27H35F3N4O11 | [MDL Number]
MFCD32878273 | [MOL File]
1799711-29-7.mol | [Molecular Weight]
648.59 |
| Hazard Information | Back Directory | [Uses]
N-(3-(2-(2-(3-Aminopropoxy)ethoxy)ethoxy)propyl)-2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamide Trifluoroacetate is a key intermediate for the synthesis of dTAG-7. |
|
|